By proceeding, you agree to our Terms of Use and Privacy Policy.
For over 50 years, Web Industries has been providing precision converting and outsource manufacturing services to innovative companies that make everything from the latest commercial airliners to juice boxes, network cables, and medical testing consumables. Materials that we've slit, spooled, cut, or printed can be found around the world and in nearly every home in North America. Web Industries fills a unique position in the marketplace. Our flexible material converting capabilities make us the bridge between you and your suppliers. Our manufacturing solutions make us the bridge between you and your customers. Our materials and process engineers get you into production quickly, and our product managers keep your costs low and margins stable. Our goal is to partner with innovative companies to get their products into the marketplace ahead of the competition. We realize the importance of our role in our customers success. Our approach is simple. We develop close, collaborate relationships with customers. We listen to their needs. We share what weve learned from our years in the business. We innovate. And, because we see ourselves as partners and not just suppliers, ultimately, thats what distinguishes us from others.For more information, please visit our website: www.webindustries.
21-22 August 2023
The 8th annual Liquid Biopsy for Disease Management: From Discovery to Clinical Use conference will review new liquid biopsies coming on the market that have increased sensitivity and are robust enough for clinical applications for measuring treatmen
Event Ended
Hybrid
Paid
Washington, DC
The point-of-care industry is poised for tremendous growth and is fueled by both the explosion of enabling technologies as well as the huge need for disruption in the medical sector as consumers demand flexibility and access to testing as well as fas
Development of companion diagnostics shows no signs of slowing down anytime soon. As the field continues to grow, it is critical that the surrounding landscape progresses with it. Partnerships between pharmaceutical and diagnostic companies can lead
22-23 August 2023
The increase in testing and demands of the COVID-19 pandemic has spurred tremendous innovation for infectious disease testing platforms that reduce time, cost, and offer greater access than ever before. At the 15th Annual Advanced Diagnostics for Inf
As diagnostics become increasingly complex, coverage and reimbursement come to the forefront of challenges that diagnostic companies face. Deep understanding of how policy is developed and implemented and how policy will change over time will provide
Current guidelines call for screening for only five types of cancer, and in each case for one type of cancer per screen. This means that there are no screening tests available for the majority of cancers, and far too often cancer is only detected onc
Within the last few years, we saw a seismic global shift in the acceptance and availability of point-of-care and home-based testing, bolstered by a heightened interest in and capability for decentralized processes. Healthcare systems and providers we